Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Other financing activities (2016 - 2025)

Fortress Biotech (FBIO) has 12 years of Other financing activities data on record, last reported at $2000.0 in Q2 2025.

  • For Q2 2025, Other financing activities changed N/A year-over-year to $2000.0; the TTM value through Sep 2025 reached $1000.0, changed N/A, while the annual FY2024 figure was -$1000.0, N/A changed from the prior year.
  • Other financing activities reached $2000.0 in Q2 2025 per FBIO's latest filing, up from -$1000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $193000.0 in Q4 2021 and bottomed at -$6000.0 in Q2 2022.
  • Average Other financing activities over 4 years is $33454.5, with a median of $2000.0 recorded in 2021.
  • Peak YoY movement for Other financing activities: plummeted 100.17% in 2021, then skyrocketed 700.0% in 2022.
  • A 4-year view of Other financing activities shows it stood at $193000.0 in 2021, then dropped by 11.4% to $171000.0 in 2022, then crashed by 98.25% to $3000.0 in 2023, then plummeted by 33.33% to $2000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other financing activities were $2000.0 in Q2 2025, -$1000.0 in Q1 2025, and $3000.0 in Q1 2023.